Inflammatory bowel disease (IBD) is a common chronic gastrointestinal disorder and current treatment strategies can cause adverse effects. Thus, there is a need to identify alternative compounds to treat IBD. Similarly, the dose-related toxicity and efficacy of anticancer drugs needs to be monitored accurately to improve the treatment outcomes.
Research reveals the importance of phytocompounds and metabolomics analysis retrieved 30 April 2024 from https://medicalxpress.com/news/2024-04-reveals-importance-phytocompounds-metabolomics-analysis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Gut bacteria and inflammatory bowel disease: Exploring the potential of prebioticsA growing body of research suggests that manipulating gut bacteria may offer a promising approach to managing inflammatory bowel disease (IBD), a chronic and debilitating condition affecting millions of people worldwide.
続きを読む »
Does IBD affect cancer risk?Research suggests no strong genetic link between inflammatory bowel disease and increased cancer risk, with specific exceptions in European populations for Crohn's disease and ulcerative colitis.
続きを読む »
Higher vitamin D levels found to cut bowel resection risk with IBDAn increased serum level of 25-hydroxyvitamin D (25[OH]D) is independently associated with a lower risk for bowel resection with inflammatory bowel disease (IBD), according to a study published online March 25 in the International Journal of Surgery.
続きを読む »
Innovative testing protocol reduces the lengthy wait for IBD diagnosisPatients with suspected inflammatory bowel disease (IBD) could benefit from better testing protocols that would reduce the need and lengthy wait for potentially unnecessary colonoscopies, a new study has found.
続きを読む »
Study identifies risk factors for extraintestinal manifestations of IBDCertain demographic, clinical, and genetic factors heighten the risk for extraintestinal manifestations (EIMs) with inflammatory bowel disease (IBD), according to a study published online March 13 in Gastroenterology.
続きを読む »
Researchers find evidence a natural juice can help gut healthA team of researchers at the University of Missouri is uncovering how the juice from red cabbage, long used in traditional medicine, can alleviate inflammation-associated digestive health conditions such as inflammatory bowel disease (IBD) in mice, offering hope to the estimated 3 million Americans who suffer from IBD, including Crohn's disease...
続きを読む »